TRHC Forms a Strategic Alliance with the American College of Apothecaries (ACA) to Market TRHC Solutions to Members
November 16 2020 - 8:45AM
Tabula Rasa HealthCare (Nasdaq: TRHC), a healthcare technology
company advancing the field of medication safety, announces today
an agreement with the American College of Apothecaries (ACA). ACA,
a national pharmacy organization dedicated to the advancement of
professional practice in independent community pharmacy through
entrepreneurship, will develop programing to educate ACA members on
TRHC’s medication safety software, MedWise™ and promote the
opportunity to become Certified MedWise Advisors™.
“Partnering with Tabula Rasa HealthCare provides our members
with access to innovative technologies, like MedWise, that will
help them improve medication safety in patients who have a high
burden of disease and complex medication regimens,” said ACA
Executive Vice President/CEO Susie Bartlemay, RPh, FACA, FAPhA.
“Our collaboration with TRHC furthers ACA’s commitment to providing
exemplary pharmacy resources to community pharmacists.”
TRHC’s MedWise software provides science-based, actionable
clinical intelligence to pharmacists, including
patients’ MedWise Risk Scores™ (MRS). The MRS uses active
ingredients of a patient’s complete medication list, including
over-the-counter supplements, to predict the risk of medication
problems and adverse drug events (ADEs) MedWise helps pharmacists
to assess simultaneous, accumulative, multi-drug interactions
amongst complex medication regimens in an efficient manner and
avoid ADEs. ADEs are largely considered preventable and are the
third leading cause of death.
“Having been a two-term President of ACA, I understand how vital
education, training, innovation and new technologies are in
supporting the entrepreneurial spirit of community pharmacists,”
states TRHC Chairman and CEO Calvin H. Knowlton, PhD. “Offering
members of ACA a way to identify high risk patients, along with the
opportunity to become certified MedWise Advisors, is just the
beginning of how our partnership will help improve medication
safety in patients who are at risk for adverse drug events, due to
their complex medication regimens.”
About Tabula Rasa HealthCareTabula Rasa
HealthCare (TRHC) provides medication safety solutions empowering
healthcare professionals to optimize medication regimens and reduce
medication-related risk, specifically targeting adverse drug
events. Utilizing its proprietary medication decision science
technology, MedWise™, TRHC improves patient outcomes, reduces
hospitalizations, and lowers healthcare costs. Additionally, TRHC
offers an extensive clinical telepharmacy network across the U.S.
Our solutions are trusted by health plans and pharmacies nationwide
to help drive value-based payment results. For more information,
visit TRHC.com.
About the American
College of Apothecaries The American College of
Apothecaries was founded on May 9, 1940 in Richmond, Virginia. In
1978, the Research & Education Foundation was established, and
in 1998 the American College of Veterinary Pharmacists began. The
existence of these three separate entities allows for the provision
of numerous benefits to the Fellowship and the profession. The
American College of Apothecaries is dedicated to the advancement of
professional practice in independent community pharmacy by
advancing the entrepreneurial spirit of member pharmacists through
education, innovation, mentoring, fellowship and training. The
American College of Apothecaries was founded on May 9, 1940 in
Richmond, Virginia. For more information, visit acainfo.org.
Forward-Looking StatementsThis press release
includes forward-looking statements that we believe to be
reasonable as of today’s date, including statements regarding
Medication Risk Mitigation technology. Such statements are
identified by use of the words “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,”
“should,” and similar expressions. These forward-looking statements
are based on management’s expectations and assumptions as of the
date of this press release. Actual results might differ materially
from those explicit or implicit in the forward-looking statements.
Important factors that could cause actual results to differ
materially include: the need to innovate and provide useful
products and services; risks related to changing healthcare and
other applicable regulations; increasing consolidation in the
healthcare industry; managing our growth effectively; our ability
to adequately protect our intellectual property; and the other risk
factors set forth from time to time in our filings with the SEC,
including those factors discussed under the caption “Risk Factors”
in our most recent annual report on Form 10-K, filed with the SEC
on March 2, 2020, and in subsequent reports filed with or furnished
to the SEC, copies of which are available free of charge within the
Investor Relations section of the TRHC
website ir.trhc.com or upon request from our Investor
Relations Department. Any forward-looking statement speaks only as
of the date on which it was made. TRHC assumes no obligation and
does not intend to update these forward-looking statements, except
as required by law, to reflect events or circumstances occurring
after today’s date.
TRHC Media ContactAmanda Bednarabednar@trhc.comT: (856)
912-5714
Dianne Semingsondsemingson@trhc.comT: (215) 870-0829
TRHC Investor ContactFrank Sparacinofsparacino@trhc.comT: (866)
648-2767
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Jul 2023 to Jul 2024